PRA Health Sciences (NASDAQ:PRAH) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, February 20th. Analysts expect the company to announce earnings of $1.02 per share for the quarter.
Shares of PRA Health Sciences (NASDAQ:PRAH) opened at $86.07 on Tuesday. PRA Health Sciences has a 12-month low of $57.72 and a 12-month high of $95.90. The stock has a market cap of $5,410.00, a PE ratio of 48.35, a P/E/G ratio of 1.16 and a beta of 0.31. The company has a debt-to-equity ratio of 1.38, a quick ratio of 1.01 and a current ratio of 1.01.
In other PRA Health Sciences news, VP Linda Baddour sold 67,000 shares of PRA Health Sciences stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $90.27, for a total transaction of $6,048,090.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider David W. Dockhorn sold 72,850 shares of PRA Health Sciences stock in a transaction dated Thursday, December 28th. The shares were sold at an average price of $90.83, for a total transaction of $6,616,965.50. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 217,815 shares of company stock valued at $19,690,710. Company insiders own 2.10% of the company’s stock.
PRA Health Sciences Company Profile
PRA Health Sciences, Inc is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases.
Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.